This article is a correction to:
Definition of the Immune Parameters Related to COVID-19 Severity
Sarah Birindelli1*
Maciej S. Tarkowski2
Marcello Gallucci3
Marco Schiuma4
Alice Covizzi4
Przemysław Lewkowicz5
Elena Aloisio1Felicia Stefania Falvella1Alberto Dolci1,2
Agostino Riva2,4Massimo Galli2,4Mauro Panteghini1,2- 1Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy
- 2Department of Biomedical and Clinical Sciences, “Luigi Sacco”, University of Milan, Milan, Italy
- 3Department of Psychology, University of Milano Bicocca, Milan, Italy
- 4Department of Infectious Diseases, Division III, ASST Fatebenefratelli-Sacco, Milan, Italy
- 5Department of Immunogenetics, Medical University of Lodz, Lodz, Poland
A Corrigendum on
Definition of the immune parameters related to COVID-19 severity
by Birindelli S, Tarkowski MS, Gallucci M, Schiuma M, Covizzi A, Lewkowicz P, Aloisio E, Falvella FS, Dolci A, Riva A, Galli M and Panteghini M (2022) Front. Immunol. 13:850846. doi: 10.3389/fimmu.2022.850846
In the published article, Clinical Chemistry and Laboratory Medicine - A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data on Sysmex XN-series analysers (10.1515/cclm-2021-0096) was not cited in the article. The citation has now been inserted in the Introduction and should read:
“Overall, this evidence supports a panhemocytometric approach to COVID-19 monitoring: lymphopenia, neutrophilia, and abnormal/activated cells are observed from the onset and appear to have discriminatory capabilities to target patients in mild or critical conditions. More important, their temporal changes may predict disease trajectory (21).”
The References section has been updated and renumbered accordingly.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Reference
Keywords: blood cell count, severity score, immunological changes, COVID-19 outcome, oxygen therapy, clinical management, triage
Citation: Birindelli S, Tarkowski MS, Gallucci M, Schiuma M, Covizzi A, Lewkowicz P, Aloisio E, Falvella FS, Dolci A, Riva A, Galli M and Panteghini M (2023) Corrigendum: Definition of the immune parameters related to COVID-19 severity. Front. Immunol. 14:1219179. doi: 10.3389/fimmu.2023.1219179
Received: 08 May 2023; Accepted: 15 May 2023;
Published: 24 May 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Birindelli, Tarkowski, Gallucci, Schiuma, Covizzi, Lewkowicz, Aloisio, Falvella, Dolci, Riva, Galli and Panteghini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sarah Birindelli, c2FyYWguYmlyaW5kZWxsaUBhc3N0LWZiZi1zYWNjby5pdA==